Lumora review
The site promises to show visit fees, medication, labs and follow-up before you commit, and publishes an amount for none of them.
The verdict
Lumora publishes estimated starting prices of $245 a month for compounded semaglutide and $325 for tirzepatide. Exact pricing is shown after a free online assessment.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $245/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Lumora sells both molecules by injection with five dose tiers on one line and six on the other. Sublingual forms are also offered. Both figures are described as estimated starting prices.
Who writes the prescription, and what do they see?
A free online assessment precedes any exact figure. The pages describe what the assessment will reveal rather than who conducts it. Five and six dose tiers exist, which implies a clinical ladder the pages do not otherwise describe.
The promise is specific and worth quoting: a reader will see full pricing — visit fees, medication, labs, follow-up — before committing. That is a better commitment than most sellers make. It is also a commitment to disclose later rather than a disclosure now, and no amount for any of the four appears anywhere on the site.
What happens when the dose goes up?
Tiers exist and their prices do not. Five semaglutide tiers and six tirzepatide tiers are named, which is more structure than most sellers admit to, and the figure attached to each arrives after the assessment.
What the price includes
Six months at $245 is $1,470 if the estimate holds, and the word estimated is doing real work there. A starting price on a five-tier ladder is the bottom rung, so a reader escalating should expect to leave it.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Dose tiers acknowledged, five and six
- Strength: A specific disclosure promise in writing
- Strength: Sublingual forms offered as well
- Limitation: No amount published for any of the four items
- Limitation: Longer supplies priced only at checkout
- Limitation: Starting price is the bottom of a ladder
- Limitation: Exact pricing requires an assessment
What the evidence says about this kind of treatment
The assessment above is about Lumora. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader willing to complete an assessment and hold the seller to its own promise.
- Wrong for
- A reader who needs a settled figure before creating an account.
The evidence behind what Lumora prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Lumora compares
| Seller | Who it suits | Go |
|---|---|---|
 LeanDose | Readers who will get the month-two rate in writing before the first charge | See LeanDose → |
 MDExam | Readers who will get the applicable figure confirmed in writing before paying | See MDExam → |
 MANÜ Telehealth | Readers who want the cost of a full dose stated before starting a low one | See MANÜ Telehealth → |
More GLP-1 telehealth sellers reviews: MDLiveMD Total WellnessMedical Health InstituteMediviveMEDVidiMeli Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What will I actually pay?
- Lumora shows exact pricing after a free online assessment. The published $245 and $325 are described as estimated starting prices.
- Does the price rise with the dose?
- The site names five semaglutide tiers and six tirzepatide tiers without publishing a figure for any of them, so a starting price is the bottom rung.
- What does tirzepatide cost?
- An estimated $325 a month to start, on a ladder the seller says runs to six dose tiers.
- Is Lumora expensive compared with other GLP-1 telehealth sellers?
- Lumora publishes a starting figure of $245/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Lumora above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.